ChatGPT-Medical guidance

The purpose of this study was to assess ChatGPT's ability and its potential risks in medical guidance for patients with MAFLD. The study was conducted in February 2023. We simulated the questions raised by patients with MAFLD, and tested 110 questions in six aspects, including concept, diagnosis, progression, prevention, treatment and comorbidity. Each question was submitted to ChatGPT three times. Appropriateness and consistency were evaluated. In the data set, we presented the questions and corresponding answers. Judgments for consistency and appropriateness and reasons were also provided.